Refine Search
(12)
(14)
(35)
(95)

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018’, provides an overview of the Human Immunodeficiency Virus (HIV) Infections (AIDS) pipeline landscape.

The report provides comprehen...

Marburg Hemorrhagic Fever - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Marburg Hemorrhagic Fever - Pipeline Review, H2 2016’, provides an overview of the Marburg Hemorrhagic Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Helicobacter pylori Infections - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Helicobacter pylori Infections - Pipeline Review, H2 2016’, provides an overview of the Helicobacter pylori Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Neisseria gonorrhoeae Infections - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neisseria gonorrhoeae Infections - Pipeline Review, H2 2016’, provides an overview of the Neisseria gonorrhoeae Infections pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Influenza B Infections - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenza B Infections - Pipeline Review, H2 2016’, provides an overview of the Influenza B Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Epstein-Barr Viral Infections - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Epstein-Barr Viral Infections - Pipeline Review, H2 2016’, provides an overview of the Epstein-Barr Viral Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Coronaviridae Infections - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Coronaviridae Infections - Pipeline Review, H2 2016’, provides an overview of the Coronaviridae Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Poxviridae Infections - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Poxviridae Infections - Pipeline Review, H2 2016’, provides an overview of the Poxviridae Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Po...

Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2016

  • $2,000
  • September 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2016’, provides an overview of the Varicella Zoster (HHV-3) Infections pipeline landscape.

The report provides comprehensive information on the therapeut...

Equine Encephalitis - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Equine Encephalitis - Pipeline Review, H2 2016’, provides an overview of the Equine Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Equine...

Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2016’, provides an overview of the Genital Warts (Condylomata Acuminata) pipeline landscape.

The report provides comprehensive information on the thera...

Dermatomycoses - Pipeline Review, H2 2016

  • $2,000
  • November 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dermatomycoses - Pipeline Review, H2 2016’, provides an overview of the Dermatomycoses pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dermatomycoses, ...

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections - Pipeline Review, H2 2016’, provides an overview of the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infe...

Streptococcal Pneumonia - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Streptococcal Pneumonia - Pipeline Review, H2 2016’, provides an overview of the Streptococcal Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Bacterial Pneumonia - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bacterial Pneumonia - Pipeline Review, H2 2016’, provides an overview of the Bacterial Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bacter...

Burkholderia Infections - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Burkholderia Infections - Pipeline Review, H2 2016’, provides an overview of the Burkholderia Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Cerebral (Fatal) Malaria - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cerebral (Fatal) Malaria - Pipeline Review, H2 2016’, provides an overview of the Cerebral (Fatal) Malaria pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2017

  • $2,000
  • September 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2017’, provides an overview of the Resistant Pseudomonas aeruginosa Infections pipeline landscape.

The report provides comprehensive information ...

Malaria - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2018’, provides an overview of the Malaria pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Malaria, complete with analysi...

Diphtheria - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diphtheria - Pipeline Review, H1 2018’, provides an overview of the Diphtheria pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diphtheria, complete wit...

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2018’, provides an overview of the Respiratory Syncytial Virus (RSV) Infections pipeline landscape.

The report provides comprehensive informatio...

Escherichia coli Infections - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Escherichia coli Infections - Pipeline Review, H1 2018’, provides an overview of the Escherichia coli Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Dengue Fever - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dengue Fever - Pipeline Review, H1 2018’, provides an overview of the Dengue Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dengue Fever, comple...

Poliomyelitis - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Poliomyelitis - Pipeline Review, H1 2018’, provides an overview of the Poliomyelitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Poliomyelitis, com...

Meningitis - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Meningitis - Pipeline Review, H1 2018’, provides an overview of the Meningitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Meningitis, complete wit...

Pertussis (Whooping Cough) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pertussis (Whooping Cough) - Pipeline Review, H1 2018’, provides an overview of the Pertussis (Whooping Cough) pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Hepatitis E - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis E - Pipeline Review, H1 2018’, provides an overview of the Hepatitis E pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis E, complete ...

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2018’, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections pipeline landscape.

The report p...

Zika Virus Infections - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Zika Virus Infections - Pipeline Review, H1 2018’, provides an overview of the Zika Virus Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Zi...

Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2018’, provides an overview of the Middle East Respiratory Syndrome (MERS) pipeline landscape.

The report provides comprehensive information on the t...

Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2018’, provides an overview of the Influenza A Virus, H7N9 Subtype Infections pipeline landscape.

The report provides comprehensive information on...

Hepatitis B - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis B - Pipeline Review, H1 2018’, provides an overview of the Hepatitis B pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis B, complete ...

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018’, provides an overview of the Methicillin-Resistant Staphylococcus aureus (MRSA) Infections pipeline landscape.

The report...

Tuberculosis - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2018’, provides an overview of the Tuberculosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Tuberculosis, comple...

Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2018’, provides an overview of the Burkholderia pseudomallei Infections (Melioidosis) pipeline landscape.

The report provides comprehensiv...

Kaposi Sarcoma - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kaposi Sarcoma - Pipeline Review, H1 2018’, provides an overview of the Kaposi Sarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Kaposi Sarcoma, ...

Rubella (German Measles) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rubella (German Measles) - Pipeline Review, H1 2018’, provides an overview of the Rubella (German Measles) pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2018’, provides an overview of the Leishmaniasis (Kala-Azar) pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2018’, provides an overview of the Cytomegalovirus (HHV-5) Infections pipeline landscape.

The report provides comprehensive information on the therapeutic...

Q Fever - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Q Fever - Pipeline Review, H1 2018’, provides an overview of the Q Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Q Fever, complete with analysi...

Vancomycin-Resistant Enterococcus faecium Infections - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Vancomycin-Resistant Enterococcus faecium Infections - Pipeline Review, H1 2018’, provides an overview of the Vancomycin-Resistant Enterococcus faecium Infections pipeline landscape.

The report provides comprehe...

Impetigo - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Impetigo - Pipeline Review, H1 2018’, provides an overview of the Impetigo pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Impetigo, complete with anal...

Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018’, provides an overview of the Tinea pedis (Athlete Foot) pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Toxoplasmosis - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Toxoplasmosis - Pipeline Review, H1 2018’, provides an overview of the Toxoplasmosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Toxoplasmosis, com...

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2018’, provides an overview of the Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infect...

Hepatitis C - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H2 2018’, provides an overview of the Hepatitis C pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete ...

Herpes Zoster (Shingles) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Herpes Zoster (Shingles) - Pipeline Review, H2 2018’, provides an overview of the Herpes Zoster (Shingles) pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

West Nile Virus Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘West Nile Virus Infections - Pipeline Review, H2 2018’, provides an overview of the West Nile Virus Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Tetanus - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tetanus - Pipeline Review, H2 2018’, provides an overview of the Tetanus pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Tetanus, complete with analysi...

Rhinovirus Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rhinovirus Infections - Pipeline Review, H2 2018’, provides an overview of the Rhinovirus Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rh...

Chlamydia Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chlamydia Infections - Pipeline Review, H2 2018’, provides an overview of the Chlamydia Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chla...

Influenzavirus B Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenzavirus B Infections - Pipeline Review, H2 2018’, provides an overview of the Influenzavirus B Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Schistosomiasis - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Schistosomiasis - Pipeline Review, H2 2018’, provides an overview of the Schistosomiasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Schistosomiasi...

Pyelonephritis - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pyelonephritis - Pipeline Review, H2 2018’, provides an overview of the Pyelonephritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pyelonephritis, ...

Hand, Foot and Mouth Disease - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hand, Foot and Mouth Disease - Pipeline Review, H2 2018’, provides an overview of the Hand, Foot and Mouth Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2018’, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) pipeline landscape.

The report provides comprehensive info...

Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2018’, provides an overview of the Pseudomonas aeruginosa Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2018’, provides an overview of the Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline landscape.

The report provides comprehens...

Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018’, provides an overview of the Epstein–Barr Virus (HHV-4) Infections pipeline landscape.

The report provides comprehensive information on the thera...

Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2018’, provides an overview of the Lassa Fever (Lassa Hemorrhagic Fever) pipeline landscape.

The report provides comprehensive information on the thera...

Measles - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Measles - Pipeline Review, H2 2018’, provides an overview of the Measles pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Measles, complete with analysi...

Yellow Fever - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Yellow Fever - Pipeline Review, H2 2018’, provides an overview of the Yellow Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Yellow Fever, comple...

Chikungunya Fever - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chikungunya Fever - Pipeline Review, H2 2018’, provides an overview of the Chikungunya Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chikunguny...

Rotavirus Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rotavirus Infections - Pipeline Review, H2 2018’, provides an overview of the Rotavirus Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rota...

Haemophilus influenzae Type B Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Haemophilus influenzae Type B Infections - Pipeline Review, H2 2018’, provides an overview of the Haemophilus influenzae Type B Infections pipeline landscape.

The report provides comprehensive information on the...

Klebsiella pneumoniae Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Klebsiella pneumoniae Infections - Pipeline Review, H2 2018’, provides an overview of the Klebsiella pneumoniae Infections pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Pseudomonas aeruginosa Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pseudomonas aeruginosa Infections - Pipeline Review, H2 2018’, provides an overview of the Pseudomonas aeruginosa Infections pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Human Parainfluenza Virus 3 Infections - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Human Parainfluenza Virus 3 Infections - Pipeline Review, H2 2018’, provides an overview of the Human Parainfluenza Virus 3 Infections pipeline landscape.

The report provides comprehensive information on the the...

Rabies - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rabies - Pipeline Review, H2 2018’, provides an overview of the Rabies pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rabies, complete with analysis b...

Hepatitis A - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis A - Pipeline Review, H2 2018’, provides an overview of the Hepatitis A pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis A, complete ...

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2018’, provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape.

The report provides comprehensive information on t...

Hepatitis D - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis D - Pipeline Review, H2 2018’, provides an overview of the Hepatitis D pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis D, complete ...

Acinetobacter Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acinetobacter Infections - Pipeline Review, H2 2018’, provides an overview of the Acinetobacter Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Neisseria meningitidis Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neisseria meningitidis Infections - Pipeline Review, H2 2018’, provides an overview of the Neisseria meningitidis Infections pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2018’, provides an overview of the Clostridium difficile Infections (Clostridium difficile Associated Disease) pipeline ...